1. Voora Deepak
2. Dzau Victor J
3. Ginsburg Geoffrey S

9789350252758

10.5005/jp/books/11124_114

1/e

2013

18

1. Duke University School of Medicine, Durham, North Carolina, Duke University, Durham, North Carolina, USA
2. Duke School of Medicine, Durham North Carolina, USA
3. Duke University School of Medicine, Durham, North Carolina, USA, Duke University, Durham, North Carolina, USA

Pharmacogenomics, anticoagulation, clopidogrel, pharmacogenetics, pharmacokinetic variation, pharmacodynamic variation, warfarin, vitamin K reductase, nonsteroidal anti-inflammatory agents, low-density lipoprotein, heterogeneity, statin therapy, apolipoprotein E, nonsynonymous polymorphisms, atorvastatin, intensive statin therapy, C-reactive protein, rhabdomyolysis, statin metabolites, simvastatin-induced myopathy, acute coronary syndromes, ticlopidine, ATP-binding cassette, stent thrombosis, thienopyridine therapy, S-warfarin, tailored warfarin therapy, antihypertensive therapy, beta-adrenergic receptor antagonists, beta-blocker therapy, heart failure therapies, G-protein coupled receptor, metoprolol metabolism, left ventricular assist devices, central nervous system, drug therapy, extensive metabolizer, ultra metabolizer